Palisade Bio Inc. (PALI) Social Stream
PALISADE BIO INC (PALI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PALI.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-02 | 1 | $7 | $7 | $7 | $0.583 | 1100.69% |
| 2022-03-25 | 2 | $7 | $5 | $6 | $0.583 | 929.16% |
| 2022-05-17 | 2 | $5 | $3 | $4 | $0.583 | 586.11% |
| 2022-08-23 | 2 | $3 | $1.5 | $2.25 | $0.583 | 285.93% |
| 2023-03-26 | 2 | $25 | $25 | $25 | $0.583 | 4188.16% |
| 2023-03-30 | 2 | $50 | $25 | $37.5 | $0.583 | 6332.25% |
| 2023-05-17 | 2 | $50 | $16 | $33 | $0.583 | 5560.38% |
| 2023-10-27 | 2 | $3 | $3 | $3 | $0.583 | 414.58% |
| 2023-11-20 | 2 | $3 | $1.5 | $2.25 | $0.583 | 285.93% |
Price Target Last Issued September 2, 2021
The Trend in the Analyst Price Target
PALI's average price target has moved down $13.75 over the prior 27 weeks.
PALI reports an average of 925.86% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-01 | 2 | 25 | 25.0 | 25.00 | 2.710 | 822.51% |
| 2023-03-26 | 2 | 25 | 25.0 | 25.00 | 1.640 | 1424.39% |
| 2023-03-30 | 2 | 50 | 25.0 | 37.50 | 2.650 | 1315.09% |
| 2023-05-17 | 2 | 16 | 16.0 | 16.00 | 1.610 | 893.79% |
| 2023-11-17 | 2 | 3 | 1.5 | 2.25 | 0.605 | 271.9% |
PALI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 26 weeks, PALI's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, PALISADE BIO INC's number of analysts covering the stock is higher than 32.12% of them.
- PALI has a higher upside potential (average analyst target price relative to current price) than 1141.97% of all US stocks.
- PALISADE BIO INC's variance in analysts' estimates is lower than -225.04% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of stocks in the small market cap category, PALISADE BIO INC's average analyst price target is greater than 425.27% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PALISADE BIO INC are CRDF, BCLI, and CRIS.
View All Top Stocks by Price Target
Is PALI a Buy, Hold or Sell? See the POWR Ratings now!